ScienceStanford researchers build a virtual biotech company with tens of thousands of AI agents
Stanford Medicine says the agents were trained in different aspects of drug development, putting them to work on drug discovery.
TLDR
Stanford Medicine says its researchers and colleagues created a virtual biotech company with tens of thousands of AI agents. A post discussing the work says the agents analyzed and catalogued 55,984 clinical trials; citing Stanford, it says roughly 50,000 trials were processed in less than a week. That account also describes an investigation of B7-H3 (CD276) in lung cancer and a proposed antibody-drug conjugate designed to deliver a toxic chemotherapy the available reporting to cells carrying B7-H3.
Combined views
39.4K
3 Sources, first seen 6d ago
Stanford researchers build a virtual biotech company with tens of thousands of AI agents
Stanford Medicine says the agents were trained in different aspects of drug development, putting them to work on drug discovery.